Pharmaceutical News

RSS

Opioid use may increase the risk of pancreatic cancer

Researchers at Rush University Medical Center have found that opioid use might increase a person's risk of developing pancreatic cancer.

6 Jan 2021

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration for its development as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) - a rare disease for which there is no FDA-approved first-line therapy.

6 Jan 2021

UCI study first to identify and characterize 'pharmacy deserts' in California

In the United States, Black, Latino and low-income communities have historically lacked nearby access to pharmacy services.

6 Jan 2021

Novel drug may help treat osteoporosis, shows study

A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients.

6 Jan 2021

Study: Antibiotics are not necessary after most endoscopic sinus surgeries

Antibiotics are not necessary for patients after most routine endoscopic sinus surgeries despite the common practice to prescribe them, according to a team led by researchers at Massachusetts Eye and Ear.

6 Jan 2021

Negative trend on Facebook may cause people to develop false perception of COVID-19 vaccine

The human papillomavirus infection, or HPV, is the most common sexually transmitted infection in the U.S., according to the Centers for Disease Control and Prevention. HPV is associated with health problems including genital warts and cancers, but a vaccine has been available since 2006 to help stop the virus.

5 Jan 2021

Researchers develop immunity monitoring to determine the efficacy of COVID-19 vaccine

As the COVID-19 vaccine becomes available to the public, immunity monitoring will play an important role in determining whether the vaccine is effective for an individual, and for how long.

5 Jan 2021

Machine-learning method can crunch data to find new uses for existing drugs

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed.

4 Jan 2021

FDA takes first steps in bringing clarity to emerging area of individualized drug development

Advances in scientific knowledge and drug development technology have provided an opportunity for new approaches to drug development, including the development of drugs for the treatment of rare diseases.

4 Jan 2021

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations.

4 Jan 2021

New effort to support those who fall on the wrong side of global vaccine divide

As SciDev.Net celebrates 20 years of reporting about the impact of science on people in low- and middle-income countries, the need for our work is greater than ever.

4 Jan 2021

Researchers discover novel therapeutic strategy for ischemic stroke using experimental model

Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that a combination of an LSU Health-patented drug and selected DHA derivatives is more effective in protecting brain cells and increasing recovery after stroke than a single drug. The findings are published in Brain Circulation, available here.

4 Jan 2021

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics are still necessary to treat hospitalized patients. One of these treatments, remdesivir, is the first and only antiviral agent of its kind that the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19.

3 Jan 2021

WHO lists Comirnaty COVID-19 mRNA vaccine for emergency use

The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.

3 Jan 2021

FDA approves first generic glucagon for injection to treat severe hypoglycemia

Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus.

28 Dec 2020

At risk of extinction, black-footed ferrets get experimental COVID vaccine

In late summer, as researchers accelerated the first clinical trials of COVID-19 vaccines for humans, a group of scientists in Colorado worked to inoculate a far more fragile species.

23 Dec 2020

Congress extends Medicare coverage of immunosuppressive drugs for kidney transplant

An estimated 375 adult kidney transplant recipients lose their transplant every year due to a lack of coverage of immunosuppressive medications after the prior 36-month Medicare coverage period.

23 Dec 2020

Long-term opioid use cannot treat chronic pain, has serious health consequences

A broken heart is often harder to heal than a broken leg. Now researchers say that a broken heart can contribute to lasting chronic pain.

22 Dec 2020

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Immune inflammatory mediators are critical in pathology, transplantation, and regenerative medicine, scientists report in The American Journal of Pathology

22 Dec 2020

Antibiotics for C-sections are effective when given after clamping the umbilical cord

Antibiotics for cesarean section births are just as effective when they're given after the umbilical cord is clamped as before clamping – the current practice – and could benefit newborns' developing microbiomes, according to Rutgers co-authored research.

21 Dec 2020

Pharmaceutical News

Opioid use may increase the risk of pancreatic cancer

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

UCI study first to identify and characterize 'pharmacy deserts' in California

Novel drug may help treat osteoporosis, shows study

Study: Antibiotics are not necessary after most endoscopic sinus surgeries

Negative trend on Facebook may cause people to develop false perception of COVID-19 vaccine

Researchers develop immunity monitoring to determine the efficacy of COVID-19 vaccine

Machine-learning method can crunch data to find new uses for existing drugs

FDA takes first steps in bringing clarity to emerging area of individualized drug development

Seniors face crushing drug costs as Congress stalls on capping Medicare out-of-pockets

New effort to support those who fall on the wrong side of global vaccine divide

Researchers discover novel therapeutic strategy for ischemic stroke using experimental model

FDA-approved COVID-19 drug should be used cautiously, says UC researcher

WHO lists Comirnaty COVID-19 mRNA vaccine for emergency use

FDA approves first generic glucagon for injection to treat severe hypoglycemia

At risk of extinction, black-footed ferrets get experimental COVID vaccine

Congress extends Medicare coverage of immunosuppressive drugs for kidney transplant

Long-term opioid use cannot treat chronic pain, has serious health consequences

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Antibiotics for C-sections are effective when given after clamping the umbilical cord

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News